Open AccessThe Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
Author(s) -
Danijel Sikic,
Helge Täubert,
Johannes Breyer,
Markus Eckstein,
Veronika Weyerer,
Bastian Keck,
Jennifer Kubon,
Wolfgang Otto,
Thomas Worst,
Maximilian C. Kriegmair,
Philipp Erben,
Arndt Hartmann,
Bernd Wullich,
Ralph M. Wirtz,
Sven Wach
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s318893
Subject(s) - cdkn2a , bladder cancer , medicine , proportional hazards model , oncology , stage (stratigraphy) , cancer , cancer research , clinical significance , survival analysis , biology , paleontology
Fibroblast growth factor receptor 3 (FGFR3) alterations are frequent in non-muscle-invasive bladder cancer (NMIBC), although current data regarding the prognostic and therapeutic relevance are inconsistent. We analyzed the prognostic role of FGFR3 mRNA expression in stage T1 NMIBC.